Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P50
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-28.93%
2024124.04%
2023-830.52%
2022110.99%
2021-45.94%
2020-0.16%
2019-69.35%
2018-54.99%
2017-6.88%
2016-47.94%